Biotech Ag Bb, 10% Owner at Esperion Therapeutics, Inc. (ESPR), bought 230,000 shares at $20.02 ($4.6M) on 2021-05-05, disclosed to the SEC on 2021-05-07.
Open-market purchase of $4.6M ESPR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.02 | 150,000 | $3.0M | 64.6% |
| 2 | $20.57 | 80,000 | $1.6M | 35.4% |
| Total | $20.21 avg | 230,000 | $4.6M | 100% |
| Filing → |
| MGNX | BUY | 2023-10-04 | $669K | — | Filing → |
| MTEM | BUY | 2023-07-19 | $4.0M | — | Filing → |
| BDTX | BUY | 2023-07-03 | $5.0M | — | Filing → |